Overview

S Ketamine Use in Total Abdominal Hysterectomy

Status:
Withdrawn
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This study investigates the effect of low dose S+ketamine compared to placebo on cumulative morphine consumption at 24 hours in women undergoing open abdominal hysterectomy with remifentanil-propofol target controlled infusion. It compares the adverse effect profile in patients receiving S+ketamine as compared to those who did not. Participants are randomly distributed in two groups of 45 patient's each.
Phase:
N/A
Details
Lead Sponsor:
KK Women's and Children's Hospital
Treatments:
Esketamine
Ketamine
Morphine